533 related articles for article (PubMed ID: 14556106)
21. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
[TBL] [Abstract][Full Text] [Related]
22. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
[TBL] [Abstract][Full Text] [Related]
23. Specificity of SPIO particles for characterization of liver hemangiomas using MRI.
Montet X; Lazeyras F; Howarth N; Mentha G; Rubbia-Brandt L; Becker CD; Vallee JP; Terrier F
Abdom Imaging; 2004; 29(1):60-70. PubMed ID: 15160755
[TBL] [Abstract][Full Text] [Related]
24. Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions.
Yoshikawa T; Mitchell DG; Hirota S; Ohno Y; Oda K; Maeda T; Fujii M; Sugimura K
J Magn Reson Imaging; 2006 May; 23(5):712-9. PubMed ID: 16568431
[TBL] [Abstract][Full Text] [Related]
25. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.
Takahama K; Amano Y; Hayashi H; Ishihara M; Kumazaki T
Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N
Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448
[TBL] [Abstract][Full Text] [Related]
28. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
Lee JM; Kim CS; Youk JH; Lee MS
Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
[TBL] [Abstract][Full Text] [Related]
29. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
[TBL] [Abstract][Full Text] [Related]
30. The role of SPIO-enhanced MRI in the detection of malignant liver lesions.
Savranoglu P; Obuz F; Karasu S; Coker A; Secil M; Sagol O; Igci E; Dicle O; Astarcioglu I
Clin Imaging; 2006; 30(6):377-81. PubMed ID: 17101405
[TBL] [Abstract][Full Text] [Related]
31. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
33. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
[TBL] [Abstract][Full Text] [Related]
34. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems.
Kim T; Murakami T; Hori M; Onishi H; Tomoda K; Nakamura H
J Magn Reson Imaging; 2009 Mar; 29(3):595-600. PubMed ID: 19243054
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227.
Harisinghani MG; Saini S; Weissleder R; Halpern EF; Schima W; Rubin DL; Stillman AE; Sica GT; Small WC; Hahn PF
Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017
[TBL] [Abstract][Full Text] [Related]
36. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
[TBL] [Abstract][Full Text] [Related]
37. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP.
Ba-Ssalamah A; Heinz-Peer G; Schima W; Schibany N; Schick S; Prokesch RW; Kaider A; Teleky B; Wrba F; Lechner G
J Magn Reson Imaging; 2000 Jun; 11(6):665-72. PubMed ID: 10862066
[TBL] [Abstract][Full Text] [Related]
38. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
39. Hepatic MRI with SPIO: detection and characterization of focal liver lesions.
Reimer P; Tombach B
Eur Radiol; 1998; 8(7):1198-204. PubMed ID: 9724439
[TBL] [Abstract][Full Text] [Related]
40. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions.
Kumano S; Murakami T; Kim T; Hori M; Okada A; Sugiura T; Noguchi Y; Kawata S; Tomoda K; Nakamura H
AJR Am J Roentgenol; 2003 Nov; 181(5):1335-9. PubMed ID: 14573430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
